B2M and amyloidosis: The first variant of β2‐m, D76N β2‐m, discovered in a French family in 2012, is responsible for a completely different type of amyloidosis characterized by deposits in internal organs and by a late onset of clinical manifestations that occur in the fifth decade of patient life.6